Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon
Transgene Detail
|
Symbol: |
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon |
Name: |
transgene insertion 632, Dimitris Kontoyiannis |
MGI ID: |
MGI:5429340 |
Synonyms: |
Tg632, TgLrTtA-HAHuRL.632, Tg(LYS2-rtTA2S*M2,tetO-ELAVL1)632Dkon |
Transgene: |
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon Location: unknown
|
Alliance: |
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon page
|
|
Strain of Origin: |
(CBA x C57BL/6)F2
|
|
Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence, Transactivator) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Mutation details: The first vector contains the human lysozyme promoter driving immune-specific expression of the tet-on effector transgene with the rtTA2S*M2 variant. A second vector contains the tetracycline responsive element driving the inducible expression of the human cDNA with an HA tag. Lines 632 and 662 were generated with five (Tg632) or two (Tg662) copies of the rtTA and comparable (six to eight) copies of the HA-ELAVL1 transgenes.
(J:102638)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:102638 Katsanou V, et al., HuR as a negative posttranscriptional modulator in inflammation. Mol Cell. 2005 Sep 16;19(6):777-89 |
All: |
2 reference(s) |
|